News & Updates

Characterized by high postpartum and postoperative recurrence rates, endometriosis requires continuous management. At a Bayer-sponsored symposium, Dr Yong-Wook Jung of Cha Gangnam Medical Center, South Korea, discussed the paradigm shift in the management of endometriosis, while Dr Pong-Mo Yuen, Director of Minimally Invasive Gynaecology at Hong Kong Sanatorium & Hospital, shared several patient cases illustrating long-term treatment with dienogest.

Darolutamide demonstrated clinically meaningful delays in pain progression and deterioration of important patient-relevant health-related quality of life (HRQoL) outcomes vs placebo in men with metastatic hormone-sensitive prostate cancer (mHSPC), according to phase III ARANOTE trial findings presented at ASCO 2025. [ASCO 2025, abstract 5004]